Skip to content
PodSubs
ShowsPeopleGuestsJobsNewsEvents
More
BlogPodCred
Menu
ShowsPeopleGuestsJobsNewsEventsBlogPodCredNetworksSign in
Join nowSign in
  • Shows
  • People
  • Jobs
  • News
  • More
    • Guests
    • Events
    • Blog
    • PodCred
    • Networks
    Join nowSign in

Global Trial Accelerators™: Fast-Tracking First-in-Human Trials, Anywhere

Global Trial Accelerators™: Fast-Tracking First-in-Human Trials, Anywhere artwork

Joseph Geraci, CSO/CTO & Co-Founder at NetraMark

May 15, 202651 minAudio
ShareXLinkedInFacebookWhatsAppEmail

In this episode, we sit down with Dr. Joseph Geraci - mathematical physicist, medical scientist, and AI innovator - to explore how artificial intelligence is transforming the future of medicine and clinical research. Dr. Geraci began his career in quantum computing and mathematical physics, earning his PhD under renowned scientist Dr. Daniel Lidar with research supported by DARPA and the U.S. Army’s Disruptive Technology Office. He later expanded his work into artificial intelligence for medicine, oncology, and neuroscience, where he uncovered a critical problem in modern healthcare: traditional disease labels often fail to capture the true complexity and diversity of patients. This realization led him to found NetraMark and develop NetraAI, a groundbreaking AI platform designed to learn from small, noisy clinical datasets. Using a novel mathematically-augmented framework and long-range memory mechanisms, NetraAI can identify hidden and explainable patient subpopulations with extraordinary precision - helping pharmaceutical companies improve clinical trial outcomes and better match treatments to the patients most likely to benefit. In this conversation, Dr. Geraci shares insights on quantum algorithms, machine learning, the limitations of modern clinical trials, and how explainable AI could redefine our understanding of disease, health, and intelligence itself.

Audio and video play straight from the show's own hosting. PodSubs stores and serves no media.

Hosts and Guests

Nobody is credited on this episode yet.

Credit the people on this episode

Be the first to rate this episode

More episodes

All episodes
  1. Michael Drues, President at Vascular Sciences

    Nov 13, 20261 hr 7 minAudio

    In this episode, we welcome Dr. Michael Drues, President of Vascular Sciences, a consulting, education, and training company specializing in medical devices, pharmaceuticals, and biotechnology. Dr. Drues holds a Ph.D....

    Credit the people on this episode

  2. Varun Kalaiarasan, PhD Researcher at University of Cincinnati

    Nov 6, 202642 minAudio

    In this episode, we sit down with Varun Kalaiarasan, a PhD researcher in Biomedical Engineering at the University of Cincinnati, whose interdisciplinary background combines mechanical engineering, applied machine...

    Credit the people on this episode

  3. Ryan Beal, Chief Executive Officer at Dyve Biosciences

    Oct 23, 202641 minAudio

    In this episode, we welcome Dr. Ryan Beal, Founder and CEO of Dyve Biosciences, to discuss an innovative transdermal drug delivery approach targeting tumor acidity to help the immune system better recognize and attack...

    Credit the people on this episode

  4. Sandi Schaible, Founder & President at Bonded in Science

    Oct 16, 202644 minAudio

    In this episode of the MedTech Podcast, we welcome Sandi Schaible, Founder of Bonded in Science and ISO TC 194 WG14/WG1 Expert. With over 25 years of experience, Sandi brings valuable insights into chemical...

    Credit the people on this episode

  5. Gennaro Maida, CEO and Founder at Denovo Innovations Group

    Oct 9, 202652 minAudio

    In this episode, we speak with Gennaro Maida, a healthcare technology executive working at the intersection of wearable technology, clinical research, and artificial intelligence. Gennaro is CEO/CMIO of Denovo...

    Credit the people on this episode